COMPANIES COVERED
YpsomedDownload FREE Report Sample
Download Free sampleNon-insulin patch pumps, also known as bolus injectors or large volume wearable injectors, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.
Non-insulin Patch Pumps Market contains market size and forecasts of Non-insulin Patch Pumps in global, including the following market information:
Global Non-insulin Patch Pumps Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Non-insulin Patch Pumps Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Non-insulin Patch Pumps companies in 2021 (%)
The global Non-insulin Patch Pumps market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
On-Body Injectors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-insulin Patch Pumps include Ypsomed, Amgen, West Pharmaceuticals, Unilife Corporation, CeQur, Sensile Medical, BD Medical, Enable Injections and Sorrel Medical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Non-insulin Patch Pumps manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-insulin Patch Pumps Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-insulin Patch Pumps Market Segment Percentages, by Type, 2021 (%)
On-Body Injectors
Off-Body Injectors
Global Non-insulin Patch Pumps Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-insulin Patch Pumps Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Home Care Settings
Others
Global Non-insulin Patch Pumps Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-insulin Patch Pumps Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-insulin Patch Pumps revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Non-insulin Patch Pumps revenues share in global market, 2021 (%)
Key companies Non-insulin Patch Pumps sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Non-insulin Patch Pumps sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ypsomed
Amgen
West Pharmaceuticals
Unilife Corporation
CeQur
Sensile Medical
BD Medical
Enable Injections
Sorrel Medical
E3D Elcam Drug Delivery Devices
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
